Geoffrey Andrew Walford MD
Diabetes, Lipid Metabolism, Clinical Pharmacology
Senior Principal Scientist, Merck
Join to View Full Profile
50 Staniford StDiabetes CenterBoston, MA 02114
Phone+1 617-726-8722
Fax+1 617-724-8534
Dr. Walford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2008
Geisel School of Medicine at DartmouthClass of 2005
Certifications & Licensure
MA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 1 citationsAuthor Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists.Margaret Wu, Ester Carballo-Jane, Haihong Zhou, Peter Zafian, Ge Dai
Nature Communications. 2024-01-23 - 1 citationsPooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies.Kelly E Duncan, Runcheng Li, Lata Maganti, Amit Kumar, S Aubrey Stoch
Clinical and Translational Science. 2024-01-01 - 2 citationsConsiderations for Cell and Gene Therapy Programs Entering the Clinical Space.Geoffrey A Walford, An Bautmans, Carol Cannon, Kelly E Duncan, Kathleen Deschamps
Clinical Pharmacology and Therapeutics. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
